Literature DB >> 17432942

Immune and protective abilities of ubiquitinated and non-ubiquitinated pseudorabies virus glycoproteins.

R Gravier1, D Dory, F Rodriguez, S Bougeard, V Beven, R Cariolet, A Jestin.   

Abstract

Plasmids encoding ubiquitinated (ubi-) or non-ubiquitinated (non-ubi-) glycoproteins of Pseudorabies virus (PRV) were used for vaccination of pigs. We found that the fusion of ubiquitin to viral glycoproteins increased their degradation in proteasomes in vitro, in which ubiquitin plays a key role. In the animals immunized with the plasmids encoding PRV ubi-glycoproteins and then challenged with PRV, we detected a slightly decreased cellular immune response on days 13 and 19 after immunization and a reduced nasal excretion of infectious virus on day 2 after the challenge. Afterwards, no effect of the ubiquitination of the glycoproteins on humoral or cellular immunity and on excretion of infectious virus was observed. Similarly, no effect of the ubiquitination on protective abilities of PRV glycoproteins was found.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17432942

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  3 in total

1.  Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis.

Authors:  Diethilde J Theil; Jane E Libbey; Fernando Rodriguez; J Lindsay Whitton; Ikuo Tsunoda; Tobias J Derfuss; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2008-11-15       Impact factor: 3.478

2.  DNA Vaccines in Pigs: From Immunization to Antigen Identification.

Authors:  Francesc Accensi; Laia Bosch-Camós; Paula L Monteagudo; Fernando Rodríguez
Journal:  Methods Mol Biol       Date:  2022

3.  Targeted Collection of Plasmid DNA in Large and Growing Animal Muscles 6 Weeks after DNA Vaccination with and without Electroporation.

Authors:  Daniel Dory; Vincent Le Moigne; Roland Cariolet; Véronique Béven; André Keranflec'h; André Jestin
Journal:  J Immunol Res       Date:  2015-08-25       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.